@article{article, title  = {{Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2023}},

 month = {{4}},

 author = {{Shaw RH and Greenland M and Stuart ASV and Aley PK and Andrews NJ and Cameron JC and Charlton S and Clutterbuck EA and Collins AM and Darton T and Dinesh T et al}},

 doi = {{10.1016/j.jinf.2023.03.027}},

 journal = {{Journal of Infection}},

 note = {{Accessed on 2024/09/19}}}